Knowledge and Attitude of Mpox disease of Quarantine, Immigration and Custom officers at International Airports in Thailand
Article Sidebar
Main Article Content
Abstract
This descriptive research aimed to study knowledges and attitudes toward Mpox disease (Monkeypox disease). The developed questionnaire was provided to 273 quarantine, immigration and custom officers at International Airports in Thailand. Data were collected from April,19 2023 to May,20 2023. The data were analyzed using frequency, percentage, mean, standard deviation, t-test, F-test, and Mann- Whinny U test product moment correlation.
The results showed that most samples were non-medical personnel (71.8%). Age of the samples was between 31 to 40 years old (33.3%). The education levels of those were mostly undergraduate (76.5%). Also, 54.9% of those samples worked at Immigration office. Knowledge toward Mpox disease was at high level ( = 6.32, SD = 1.54), while attitude was at moderate level ( = 19.73, SD=2.200.53). Comparison between the medical and non-medical personnel groups showed significant differences (p<0.05), for medical personnel obtained higher levels of both knowledges and attitudes than non-medical personnel. As our study provided relevant information against quarantine of Mpox disease at the international airports, the results of study can be used to promote knowledges and attitudes, also to promote practices to protect themselves from Mpox infection and to control emerging communicable diseases in the future.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่พิมพ์ในวารสารสถาบันป้องกันควบคุมโรคเขตเมือง ถือว่าเป็นผลงานวิชาการ งานวิจัยและวิเคราะห์ ตลอดจนเป็นความเห็นส่วนตัวของผู้เขียนเอง ไม่ใช่ความเห็นของสถาบันป้องกันควบคุมโรคเขตเมือง หรือคณะบรรณาธิการแต่ประการใด ผู้เขียนจำต้องรับผิดชอบต่อบทความของตน
References
World Health Organization [Internet]. Geneva: WHO; 2023. Mpox (monkeypox); 2023 [cite 2023 April 18]; [about 1 p.] Available from: https://www.who.int/news-room/fact-sheets/detail/monkeypox
Centers for Disease Control and Prevention [Internet]. Georgia: CDC; 2023. 2022 Global Map & Case Count; 2023 [cite 2023 April 18]; [about 1 p.] Available from: https://www.cdc.gov/poxvirus/mpox/response/2022/world-map.html
Centers for Disease Control and Prevention [Internet]. Georgia: CDC; 2023. Mpox Infections after Vaccination; 2023 [cite 2023 April 18]; [about 1 p.] Available from: https://www.cdc.gov/poxvirus/monkeypox/index.html
Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153-1162.
Alshahrani NZ, Algethami MR, Alarifi AM, Alzahrani F, Alshehri EA, Alshehri AM, et al. Knowledge and Attitude Regarding Monkeypox Virus among Physicians in Saudi Arabia: A Cross-Sectional Study. Vaccines. 2022;10(12):1-13.
Harapan H, Setiawan AM, Yufika A, Anwar S, Wahyuni S, Asrizal FW, et al. Knowledge of human monkeypox viral infection among general practitioners: a cross-sectional study in Indonesia. Pathogens and Global Health. 2020;114(2):68-75.
Simpson LA, Macdonald K, Searle EF, Shearer JA, Dimitrov D, Foley D, et al. Development and deployment of tools for rapid response notification of Monkeypox exposure, exposure risk assessment and stratification, and symptom monitoring. Infection Control & Hospital Epidemiology. 2022;43(8):963-7.
Riccò M, Ferraro P, Camisa V, Satta E, Zaniboni A, Ranzieri S, et al. When a Neglected Tropical Disease Goes Global: Knowledge, Attitudes and Practices of Italian Physicians towards Monkeypox, Preliminary Results. Tropical medicine and infectious disease. 2022;7(7):1-21.